AASLD News

Alexandria, VA – March 18, 2026 — The American Association for the Study of Liver Diseases (AASLD) supports a recent federal court ruling that temporarily blocks proposed changes to the U.S. immunization schedule, preserving access to the universal hepatitis B birth dose and routine childhood hepatitis A vaccination. The decision, issued March 16, halts implementation of changes that threatened to

The American Association for the Study of Liver Diseases (AASLD), the leading organization of scientists and health care professionals committed to preventing and curing liver disease, is pleased to announce the selection of 33 hepatology leaders as Fellows and six hepatology-focused clinicians as Associate Fellows. The Fellows program (FAASLD) bestows honorary recognition to AASLD Regular and

AASLD recently submitted formal comments to the U.S. Department of Education opposing a proposed rule that would exclude nurse practitioner (NP) and physician assistant (PA) degrees from classification as professional degrees for support from federal student loan programs. While this proposal may appear administrative in nature, its implications for the hepatology workforce and for patients living

AASLD’s Special Interest Groups (SIGs) are where ideas spark, collaborations begin, and advances in hepatology move forward. We’re excited to share an important milestone: all AASLD SIGs are now live on the AASLD SIGnal community platform. This brings the full breadth of hepatology expertise together in one collaborative, secure, members-only online space. Developed in partnership with DocMatter

AASLD invites nominations to recognize leaders advancing hepatology; recipients will be honored at The Liver Meeting® 2026 ALEXANDRIA, VA -- The American Association for the Study of Liver Diseases (AASLD) has opened nominations for its 2026 Distinguished Awards, the organization’s highest honors recognizing sustained impact in hepatology. Each year, award recipients are celebrated at The Liver

As we recognize Rare Disease Month this February and Rare Disease Day on February 28, I’m reminded that in pediatric hepatology, rare diseases are not the exception, they’re often the rule. Caring for children with complex and rare liver conditions is a profound privilege. It’s work that humbles me every day and continually renews my sense of purpose. And children, families, and patients around

ALEXANDRIA, Virginia — A new study in HEPATOLOGY, the premier journal in the field of liver disease, reports that a noninvasive imaging test may perform as well as a liver biopsy in predicting serious liver-related outcomes in metabolic dysfunction–associated steatotic liver disease (MASLD). Findings from the article “ Head-to-Head Comparison Between Vibration-Controlled Transient Elastography and

Alexandria, VA — The American Association for the Study of Liver Diseases (AASLD) announced the launch of its new Clinical Informatics and Digital Health Special Interest Group (CIDH SIG), a member-driven community focused on advancing the use of clinical informatics and digital health to improve liver disease research, care delivery, and patient outcomes. The CIDH SIG brings together

AASLD welcomes momentum in elevating lifelong liver health as a global public health priority The American Association for the Study of Liver Diseases (AASLD) welcomes the World Health Organization (WHO) Executive Board’s recent decision to advance proposals to expand the global definition of noncommunicable diseases (NCDs) to formally include liver diseases and inherited bleeding disorders. This

ALEXANDRIA, Virginia — February 3, 2026 – The American Association for the Study of Liver Diseases (AASLD) invites applications for the next Editor-in-Chief or co-Editor-in-Chief team of Hepatology Communications, its open-access, peer-reviewed journal dedicated to advancing discovery and innovation in liver science. Founded in 2017, Hepatology Communications is a monthly, online-only, open access

Alexandria, VA — The American Association for the Study of Liver Diseases (AASLD) is pleased to announce the leadership of its 2026 Governing Board. As champions in advancing liver science, care, and education, these distinguished leaders from leading academic, clinical, and research institutions across the country. The Governing Board will guide AASLD’s strategic vision and organizational mission

Dear AASLD Community, It’s truly an honor to begin this year serving as President of the American Association for the Study of Liver Diseases (AASLD). I step into this role with deep gratitude for the community that defines AASLD, respect for the leadership that preceded me, and a strong sense of responsibility for the work ahead. AASLD has been a professional home to me since I was a medical

The American Association for the Study of Liver Diseases (AASLD) expresses deep concern over the 2025–2030 Dietary Guidelines for Americans (DGA), released jointly by the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA), which remove specific, evidence-based guidance on alcohol consumption. The updated guidelines advise individuals to consume less

On January 7, 2026, the Department of Health and Human Services (HHS) and the Department of Agriculture (USDA) released updated Dietary Guidelines for Americans (DGA) for 2025-2030, removing any specific guidance on alcohol consumption. The updated guidelines instead advise that people should “consume less alcohol for better overall health” and “limit beverages,” without recommending clear limits